Evidence map›Paper›PMID 41975302›Full record

Observational studyBMC geriatrics2026

Clinical effectiveness of intensive care unit admission in older adults with COVID-19 during the first pandemic wave in Spain.

Marta Arroyo-Huidobro, Carlos Pérez-López, Natàlia Pallarès, Cristian Tebé Cordomí, Antonella F Simonetti, Gabriela Abelenda-Alonso, Alexander Rombauts, Isabel Oriol Bermudez, Elisenda Izquierdo, Vicente Díaz-Brito and 8 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marta Arroyo-HuidobroHospital Clinic de Barcelona, Geriatric Department, Universitat de Barcelona, C. de Villarroel, 170, Barcelona, 08036, Spain. arroyo@clinic.cat.
Carlos Pérez-LópezConsorci Sanitari Alt Pènedes I Garraf, Area de Recerca, Vilafranca del Penedès, Spain.
Natàlia PallarèsBiostatistics Support and Research Unit, Germans Trias I Pujol Research Institute and Hospital (IGTP), Badalona, Catalunya, Spain.
Cristian Tebé CordomíBiostatistics Support and Research Unit, Germans Trias I Pujol Research Institute and Hospital (IGTP), Badalona, Catalunya, Spain.
Antonella F SimonettiHospital de La Santa Creu I Sant Pau, Infectious Diseases Unit, Barcelona, Catalunya, Spain.
Gabriela Abelenda-AlonsoBellvitge University Hospital, L'Hospitalet de Llobregat, Catalunya, Spain.
Alexander RombautsHospital de La Santa Creu I Sant Pau, Infectious Diseases Unit, Barcelona, Catalunya, Spain.
Isabel Oriol BermudezDepartment of Internal Medicine, Consorci Sanitari Integral, L'Hospitalet de Llobregat, Catalunya, Spain.
Elisenda IzquierdoDepartment of Anaesthesiology, Hospital de Viladecans, Viladecans, Catalunya, Spain.
Vicente Díaz-BritoDepartment of Infectious Diseases, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
Gemma MolistUniversidad de Vic: Faculty of Medicine, University of Vic-Central University of Vic, Barcelona, Spain.
Guadalupe Gómez-MelisDepartment of Statistics and Operations Research and Institute for Research and Innovation in Health (IRIS), Universitat Politècnica de Catalunya -BarcelonaTech, Barcelona, Catalunya, Spain.
Sebastian VidelaDepartment of Clinical Pharmacology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalunya, Spain.
Alfons López SotoDepartment of Internal Medicine, Hospital Clinic de Barcelona, Geriatric Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, Catalunya, Spain.
Jordi CarratalàDepartment of Infectious Diseases, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Catalunya, Spain.
Alejandro Rodríguez-MolineroConsorci Sanitari Alt Pènedes I Garraf, Area de Recerca, Vilafranca del Penedès, Spain.
MetroSud
Divine study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the impact of ICU admission on mortality and complications of older patients with COVID-19 hospitalized during the first COVID-19 wave in our setting.

methodsAn observational, multicenter, and ambispective study of COVID-19 patients aged > 70 years who were hospitalized during the first wave of the pandemic in the southern metropolitan area of Barcelona, Spain. The primary outcome of the study was the in-hospital mortality rate of patients admitted to the ICU compared with their appropriately matched controls who received care in hospital wards. The secondary outcome was the in-hospital rate of complications in ICU-admitted patients versus their matched controls.

resultsThe mortality rate was 76.6% in ICU-admitted patients and 64.9% among their matched controls, whereas the corresponding rates of complications were 73.5% and 32.4%, respectively. ICU admission shows a statistically significant impact on mortality (OR [95% CI] 2.50 [1.06–6.05]; p = 0.041). Additionally, complications were four times more likely in patients who were admitted to ICUs than in those admitted to general wards (OR [95% CI] 4.03 [1.64–9.91]; p = 0.0024).

conclusionsICU admission was not associated with improved survival in patients older than 70 years during the first COVID-19 wave. Further research is needed to confirm these findings and to assess the adequacy of ICU admission criteria for elderly patients.

trial registrationNot applicable.

Indexed as

COVID-19Hospital MortalityIntensive Care UnitsPandemicsPatient AdmissionAgedAged, 80 and overFemaleHumansMaleSpainClinical complicationsCOVID-19Intensive care unitMortalityOlder adults

Identifiers

PMID41975302
PMCPMC13195834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.